New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Blood markers of brain cell damage higher over short term in COVID-19 patients than in Alzheimer's patients

Blood markers of brain cell damage higher over short term in COVID-19 patients than in Alzheimer's patients

by NYU Langone HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainPatients hospitalized for COVID-19 had higher levels over the short term of blood proteins known
Neurology May 22,2024
Blood markers of brain cell damage higher over short term in COVID-19 patients than in Alzheimer's patients

Blood markers of brain cell damage higher over short term in COVID-19 patients than in Alzheimer's patients

by NYU Langone HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainPatients hospitalized for COVID-19 had higher levels over the short term of blood proteins known
Neurology May 22,2024
Insights on FDA's controversial approval of Alzheimer's drug

Insights on FDA's controversial approval of Alzheimer's drug

by Patrick Ercolano,Johns Hopkins UniversitySupriya Munshaw. Credit: Johns Hopkins UniversityThe U.S. Food and Drug Administration's recent approval of aducanumab, a treatment for Alzheimer&
Neurology May 22,2024
Insights on FDA's controversial approval of Alzheimer's drug

Insights on FDA's controversial approval of Alzheimer's drug

by Patrick Ercolano,Johns Hopkins UniversitySupriya Munshaw. Credit: Johns Hopkins UniversityThe U.S. Food and Drug Administration's recent approval of aducanumab, a treatment for Alzheimer&
Neurology May 22,2024
Protein that regulates brain cell connections could be new target for treating Alzheimer's disease

Protein that regulates brain cell connections could be new target for treating Alzheimer's disease

by Johns Hopkins University School of MedicineDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.In experiments with a protein called Ephexin5 that app
Neurology May 22,2024
Protein that regulates brain cell connections could be new target for treating Alzheimer's disease

Protein that regulates brain cell connections could be new target for treating Alzheimer's disease

by Johns Hopkins University School of MedicineDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.In experiments with a protein called Ephexin5 that app
Neurology May 22,2024
Arterial stiffening linked to Alzheimer's disease

Arterial stiffening linked to Alzheimer's disease

by Paul Govern,Vanderbilt UniversityCredit: Pixabay/CC0 Public DomainA research team from Vanderbilt University Medical Center reports inNeurologythat greater stiffening of the aorta
Neurology May 22,2024
Arterial stiffening linked to Alzheimer's disease

Arterial stiffening linked to Alzheimer's disease

by Paul Govern,Vanderbilt UniversityCredit: Pixabay/CC0 Public DomainA research team from Vanderbilt University Medical Center reports inNeurologythat greater stiffening of the aorta
Neurology May 22,2024
Gene therapy using 'zinc fingers' may help treat Alzheimer's disease, animal study shows

Gene therapy using 'zinc fingers' may help treat Alzheimer's disease, animal study shows

by Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainResearchers have used a genetic engineering strategy to dramatically reduce levels of tau—a key protein that accumulates and beco
Neurology May 22,2024
Gene therapy using 'zinc fingers' may help treat Alzheimer's disease, animal study shows

Gene therapy using 'zinc fingers' may help treat Alzheimer's disease, animal study shows

by Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainResearchers have used a genetic engineering strategy to dramatically reduce levels of tau—a key protein that accumulates and beco
Neurology May 22,2024
Electronic health records help study drug-effectiveness in Alzheimer's disease

Electronic health records help study drug-effectiveness in Alzheimer's disease

by Case Western Reserve UniversityCredit: CC0 Public DomainResearchers have harnessed the power of electronic health records to gain insight in the potential of inflammation-controlling medicatio
Neurology May 22,2024
Electronic health records help study drug-effectiveness in Alzheimer's disease

Electronic health records help study drug-effectiveness in Alzheimer's disease

by Case Western Reserve UniversityCredit: CC0 Public DomainResearchers have harnessed the power of electronic health records to gain insight in the potential of inflammation-controlling medicatio
Neurology May 22,2024
Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

by Perelman School of Medicine at the University of PennsylvaniaPET imaging using the radiotracers FDG and florbetapir to quantify cognitive decline in patients with Alzheimer’s disease (AD), mil
Neurology May 22,2024
Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

by Perelman School of Medicine at the University of PennsylvaniaPET imaging using the radiotracers FDG and florbetapir to quantify cognitive decline in patients with Alzheimer’s disease (AD), mil
Neurology May 22,2024
Shorter telomeres point to increased Alzheimer's risk

Shorter telomeres point to increased Alzheimer's risk

by Kim Krieger,University of ConnecticutHuman chromosomes (grey) capped by telomeres (white). Credit: PD-NASA; PD-USGOV-NASAShort telomeres in midlife are associated with a higher risk of develo
Neurology May 22,2024
Shorter telomeres point to increased Alzheimer's risk

Shorter telomeres point to increased Alzheimer's risk

by Kim Krieger,University of ConnecticutHuman chromosomes (grey) capped by telomeres (white). Credit: PD-NASA; PD-USGOV-NASAShort telomeres in midlife are associated with a higher risk of develo
Neurology May 22,2024
Alzheimer's disease could be treated with gene therapy, animal study suggests

Alzheimer's disease could be treated with gene therapy, animal study suggests

by Imperial College LondonBrain cells from a mouse cortex that didn't receive the gene therapy. The amyloid plaques are shown in green, and the glial cells, which surround the plaques, are sh
Neurology May 22,2024
Alzheimer's disease could be treated with gene therapy, animal study suggests

Alzheimer's disease could be treated with gene therapy, animal study suggests

by Imperial College LondonBrain cells from a mouse cortex that didn't receive the gene therapy. The amyloid plaques are shown in green, and the glial cells, which surround the plaques, are sh
Neurology May 22,2024
Blood test biomarker reveals status of neurological diseases in kids, even without symptoms

Blood test biomarker reveals status of neurological diseases in kids, even without symptoms

by Suzanne Leigh,University of California, San FranciscoCredit: Pixabay/CC0 Public DomainAn experimental method developed to detect nerve injury in multiple sclerosis (MS) in adults also works f
Pediatrics May 22,2024
Blood test biomarker reveals status of neurological diseases in kids, even without symptoms

Blood test biomarker reveals status of neurological diseases in kids, even without symptoms

by Suzanne Leigh,University of California, San FranciscoCredit: Pixabay/CC0 Public DomainAn experimental method developed to detect nerve injury in multiple sclerosis (MS) in adults also works f
Pediatrics May 22,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com